Gene Therapy for Angiogenesis in the Treatment of Cardiovascular and Peripheral Arterial Disease

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/978-1-59259-934-9_8
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Amputation for occusive arterial disease

  2004cited by this paper
• Local Gene Transfer of phVEGF-2 Plasmid by Gene-Eluting Stents: An Alternative Strategy for Inhibition of Restenosis

  2004cited by this paper
• Safety and Feasibility of Catheter-Based Local Intracoronary Vascular Endothelial Growth Factor Gene Transfer in the Prevention of Postangioplasty and In-Stent Restenosis and in the Treatment of Chronic Myocardial Ischemia: Phase II Results of the Kuopio Angiogenesis Trial (KAT)

  2003cited by this paper
• Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial.

  2002cited by this paper
• A patient-derived perspective of health-related quality of life with peripheral arterial disease.

  2002cited by this paper
• Phase 1/2 Placebo-Controlled, Double-Blind, Dose-Escalating Trial of Myocardial Vascular Endothelial Growth Factor 2 Gene Transfer by Catheter Delivery in Patients With Chronic Myocardial Ischemia

  2002cited by this paper
• Ernest Henry Starling, His Predecessors, and the “Law of the Heart”

  2002cited by this paper
• Naked plasmid DNA encoding fibroblast growth factor type 1 for the treatment of end-stage unreconstructible lower extremity ischemia: preliminary results of a phase I trial.

  2002cited by this paper
• Angiogenic Gene Therapy (AGENT) Trial in Patients With Stable Angina Pectoris

  2002cited by this paper
• Clinical and Physiological Effects of an Acute &agr;-1 Adrenergic Agonist and a &bgr;-1 Adrenergic Antagonist in Chronic Orthostatic Intolerance

  2002cited by this paper
• Design of the therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (TRAFFIC) trial.

  2001cited by this paper
• Vascular endothelial growth factor enhances atherosclerotic plaque progression

  2001cited by this paper
• Assessment of risks associated with cardiovascular gene therapy in human subjects.

  2001cited by this paper
• Intracoronary administration of recombinant human vascular endothelial growth factor to patients with coronary artery disease.

  2001cited by this paper
• Adenovirus-Mediated Gene Transfer of VEGF121 Improves Lower-Extremity Endothelial Function and Flow Reserve

  2001cited by this paper
• Lower-Extremity Edema Associated with Gene Transfer of Naked DNA Encoding Vascular Endothelial Growth Factor

  2000cited by this paper
• Catheter-Mediated Vascular Endothelial Growth Factor Gene Transfer to Human Coronary Arteries after Angioplasty

  2000cited by this paper
• Intracoronary basic fibroblast growth factor enhances myocardial collateral perfusion in dogs.

  2000cited by this paper
• Basic fibroblast growth factor in patients with intermittent claudication: results of a phase I trial.

  2000cited by this paper
• Vascular endothelial growth factor(165) gene transfer augments circulating endothelial progenitor cells in human subjects.

  2000cited by this paper
• Results from late-breaking clinical trials sessions at ACCIS 2000 and ACC 2000. American College of Cardiology.

  2000cited by this paper
• Focal angiogen therapy using intramyocardial delivery of an adenovirus vector coding for vascular endothelial growth factor 121.

  2000cited by this paper
• Intracoronary basic fibroblast growth factor (FGF-2) in patients with severe ischemic heart disease: results of a phase I open-label dose escalation study.

  2000cited by this paper
• [Induction of myocardial neoangiogenesis by human growth factors. A new therapeutic approach in coronary heart disease].

  2000cited by this paper
• Effects of a single intracoronary injection of basic fibroblast growth factor in stable angina pectoris.

  2000cited by this paper
• Mechanisms of angiogenesis and arteriogenesis

  2000cited by this paper
• Therapeutic Angiogenesis With Recombinant Fibroblast Growth Factor-2 Improves Stress and Rest Myocardial Perfusion Abnormalities in Patients With Severe Symptomatic Chronic Coronary Artery Disease

  2000cited by this paper
• Electromagnetic guidance for catheter-based transendocardial injection: a platform for intramyocardial angiogenesis therapy. Results in normal and ischemic porcine models.

  2000cited by this paper
• Endovascular Brachytherapy for Prophylaxis of Restenosis After Femoropopliteal Angioplasty: Results of a Prospective Randomized Study

  2000cited by this paper
• Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization.

  2000cited by this paper
• VEGF gene transfer mobilizes endothelial progenitor cells in patients with inoperable coronary disease.

  2000cited by this paper
• Evaluation of the effects of intramyocardial injection of DNA expressing vascular endothelial growth factor (VEGF) in a myocardial infarction model in the rat--angiogenesis and angioma formation.

  2000cited by this paper
• Transmyocardial revascularization with CO2 laser in patients with refractory angina pectoris. Clinical results from the Norwegian randomized trial.

  2000cited by this paper
• Left Ventricular Electromechanical Mapping to Assess Efficacy of phVEGF165 Gene Transfer for Therapeutic Angiogenesis in Chronic Myocardial Ischemia

  2000cited by this paper
• Comparison of transmyocardial revascularization with medical therapy in patients with refractory angina.

  1999cited by this paper
• Intraoperative Multiplane Transesophageal Echocardiography for Guiding Direct Myocardial Gene Transfer of Vascular Endothelial Growth Factor in Patients with Refractory Angina Pectoris

  1999cited by this paper
• Transmyocardial laser revascularisation in patients with refractory angina: a randomised controlled trial.

  1999cited by this paper
• Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery: results of a phase I randomized, double-blind, placebo-controlled trial.

  1999cited by this paper
• Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease.

  1999cited by this paper
• Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1.

  1999cited by this paper
• Transmyocardial laser revascularisation compared with continued medical therapy for treatment of refractory angina pectoris: a prospective randomised trial. ATLANTIC Investigators. Angina Treatments-Lasers and Normal Therapies in Comparison.

  1999cited by this paper
• Myocardial Perfusion : Evidence for a Dose-Dependent Effect Effect of Intracoronary Recombinant Human Vascular Endothelial Growth Factor on

  1999cited by this paper
• Catheter-based myocardial gene transfer utilizing nonfluoroscopic electromechanical left ventricular mapping.

  1999cited by this paper
• VEGF contributes to postnatal neovascularization by mobilizing bone marrow‐derived endothelial progenitor cells

  1999cited by this paper
• Treatment of Bleomycin-Induced Pulmonary Fibrosis by Transfer of Urokinase-Type Plasminogen Activator Genes

  1999cited by this paper
• Meeting highlights. Highlights of the 48th scientific sessions of the American College of Cardiology.

  1999cited by this paper
• Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF.

  1999cited by this paper
• Transmyocardial revascularization with a carbon dioxide laser in patients with end-stage coronary artery disease.

  1999cited by this paper
• Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice.

  1999cited by this paper
• Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization.

  1999cited by this paper
• Adenoviral-mediated gene transfer induces sustained pericardial VEGF expression in dogs: effect on myocardial angiogenesis.

  1999cited by this paper
• Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization

  1999cited by this paper
• VEGF administration in chronic myocardial ischemia in pigs.

  1998cited by this paper
• Nitric oxide synthase modulates angiogenesis in response to tissue ischemia.

  1998cited by this paper
• Angiogenic potential of perivascularly delivered aFGF in a porcine model of chronic myocardial ischemia.

  1998cited by this paper
• Hibernating myocardium.

  1998cited by this paper
• Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia.

  1998cited by this paper
• Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease.

  1998cited by this paper
• VEGF gene delivery to muscle: potential role for vasculogenesis in adults.

  1998cited by this paper
• Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb.

  1998cited by this paper
• Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions: possible pathophysiological significance of VEGF in progression of atherosclerosis.

  1998cited by this paper
• Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia.

  1998cited by this paper
• Therapeutic angiogenesis with basic fibroblast growth factor: technique and early results.

  1998cited by this paper
• Treatment of thromboangiitis obliterans (Buerger's disease) by intramuscular gene transfer of vascular endothelial growth factor: preliminary clinical results.

  1998cited by this paper
• Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heart.

  1998cited by this paper
• Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia.

  1998cited by this paper
• The stimulation of neoangiogenesis in the ischemic human heart by the growth factor FGF: first clinical results.

  1998cited by this paper
• Results of intracoronary recombinant human vascular endothelial growth factor (rhVEGF) administration trial

  1998cited by this paper
• Stent endothelialization. Time course, impact of local catheter delivery, feasibility of recombinant protein administration, and response to cytokine expedition.

  1997cited by this paper
• Isolation of Putative Progenitor Endothelial Cells for Angiogenesis

  1997cited by this paper
• Passivation of metallic stents after arterial gene transfer of phVEGF165 inhibits thrombus formation and intimal thickening.

  1997cited by this paper
• Mechanisms of angiogenesis

  1997cited by this paper
• Molecular analysis of blood vessel formation and disease.

  1997cited by this paper
• Vascular endothelial growth factor/vascular permeability factor augments nitric oxide release from quiescent rabbit and human vascular endothelium.

  1997cited by this paper
• Hyperplasia of lymphatic vessels in VEGF-C transgenic mice.

  1997cited by this paper
• Vascular endothelial growth factor/vascular permeability factor produces nitric oxide-dependent hypotension. Evidence for a maintenance role in quiescent adult endothelium.

  1997cited by this paper
• Arterial gene transfer of acidic fibroblast growth factor for therapeutic angiogenesis in vivo: critical role of secretion signal in use of naked DNA.

  1997cited by this paper
• Therapeutic angiogenesis following arterial gene transfer of vascular endothelial growth factor in a rabbit model of hindlimb ischemia.

  1996cited by this paper
• Basic fibroblast growth factor increases collateral blood flow in rats with femoral arterial ligation.

  1996cited by this paper
• Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb.

  1996cited by this paper
• Increased expression of direct gene transfer into skeletal muscles observed after acute ischemic injury in rats.

  1996cited by this paper
• Accelerated restitution of endothelial integrity and endothelium-dependent function after phVEGF165 gene transfer.

  1996cited by this paper
• Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development and the arterial response to injury.

  1996cited by this paper
• Gene transfer of naked DNA encoding for three isoforms of vascular endothelial growth factor stimulates collateral development in vivo.

  1996cited by this paper
• VEGF improves myocardial blood flow but produces EDRF-mediated hypotension in porcine hearts.

  1996cited by this paper
• Intracoronary gene transfer of fibroblast growth factor–5 increases blood flow and contractile function in an ischemic region of the heart

  1996cited by this paper
• Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion.

  1996cited by this paper
• Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression.

  1996cited by this paper
• Amputation for premature peripheral atherosclerosis: do young patients do better?

  1996cited by this paper
• Mechanism of impaired myocardial function during progressive coronary stenosis in conscious pigs. Hibernation versus stunning?

  1995cited by this paper
• Effects of chronic systemic administration of basic fibroblast growth factor on collateral development in the canine heart.

  1995cited by this paper
• Low-efficiency of percutaneous adenovirus-mediated arterial gene transfer in the atherosclerotic rabbit.

  1995cited by this paper
• Late outcomes of limb loss after failed infrainguinal bypass.

  1995cited by this paper
• Differentiation of endothelium

  1995cited by this paper
• Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice

  1995cited by this paper
• Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium

  1995cited by this paper
• Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery.

  1995cited by this paper
• Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.

  1994cited by this paper
• Time course of recombinant protein secretion after liposome-mediated gene transfer in a rabbit arterial organ culture model.

  1994cited by this paper
• Basic fibroblast growth factor enhances myocardial collateral flow in a canine model.

  1994cited by this paper

• Neovascularization and Hematopoietic Stem Cells

  2013cites this paper